Skip Navigation

Human Molecular Genetics 2007 16(R1):R28-R49; doi:10.1093/hmg/ddm021
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Miremadi, A.
Right arrow Articles by Caldas, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miremadi, A.
Right arrow Articles by Caldas, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Cancer genetics of epigenetic genes

Ahmad Miremadi1, Mikkel Z. Oestergaard2, Paul D.P. Pharoah1,2 and Carlos Caldas1,*

1 Cancer Genomics Program, Department of Oncology, Hutchison/MRC Research Centre and 2 Department of Public Health, Strangeways Research Laboratories, University of Cambridge, Cambridge, UK

* To whom correspondence should be addressed at: Breast Cancer Functional Genomics Laboratory, Cancer Research UK, Cambridge Research Institute and Department of Oncology, University of Cambridge, Li Ka-Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. Email: cc234{at}cam.ac.uk

Received January 9, 2007; Revised February 7, 2007; The cancer epigenome is characterised by specific DNA methylation and chromatin modification patterns. The proteins that mediate these changes are encoded by the epigenetics genes here defined as: DNA methyltransferases (DNMT), methyl-CpG-binding domain (MBD) proteins, histone acetyltransferases (HAT), histone deacetylases (HDAC), histone methyltransferases (HMT) and histone demethylases. We review the evidence that these genes can be targeted by mutations and expression changes in human cancers.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cancer Res.Home page
P. P. Levings, S. V. McGarry, T. P. Currie, D. M. Nickerson, S. McClellan, S. C. Ghivizzani, D. A. Steindler, and C. P. Gibbs
Expression of an Exogenous Human Oct-4 Promoter Identifies Tumor-Initiating Cells in Osteosarcoma
Cancer Res., July 15, 2009; 69(14): 5648 - 5655.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
I. Lopez de Silanes, M. Gorospe, H. Taniguchi, K. Abdelmohsen, S. Srikantan, M. Alaminos, M. Berdasco, R. G. Urdinguio, M. F. Fraga, F. V. Jacinto, et al.
The RNA-binding protein HuR regulates DNA methylation through stabilization of DNMT3b mRNA
Nucleic Acids Res., May 1, 2009; 37(8): 2658 - 2671.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
M.-Y. Wu, K. W. Eldin, and A. L. Beaudet
Identification of Chromatin Remodeling Genes Arid4a and Arid4b as Leukemia Suppressor Genes
J Natl Cancer Inst, September 3, 2008; 100(17): 1247 - 1259.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. I. Joensuu, W. M. Abdel-Rahman, M. Ollikainen, S. Ruosaari, S. Knuutila, and P. Peltomaki
Epigenetic Signatures of Familial Cancer Are Characteristic of Tumor Type and Family Category
Cancer Res., June 15, 2008; 68(12): 4597 - 4605.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.